» Articles » PMID: 7716810

Jaks and Stats in Signaling by the Cytokine Receptor Superfamily

Overview
Journal Trends Genet
Specialty Genetics
Date 1995 Feb 1
PMID 7716810
Citations 202
Authors
Affiliations
Soon will be listed here.
Abstract

Many cytokines mediate their biological effects through interaction with a distinct family of receptors termed the cytokine receptor superfamily. Although members of this family lack catalytic domains, they couple ligand binding to tyrosine phosphorylation. Recent studies have shown that a novel family of cytoplasmic protein tyrosine kinases, termed the Janus kinases (Jaks), associate with the cytokine receptors and are catalytically activated after ligand binding. The activated Jaks phosphorylate and activate members of a novel family of transcription factors termed signal transducers and activators of transcription (Stats). In addition, many cytokines induce the phosphorylation of SHC, Vav and the p85 subunit of PI-3 kinase. The region of the receptors proximal to the cytoplasmic membrane is required for Jak association, mitogenesis, Stat activation and Vav phosphorylation. The membrane-distal region, which contains the major sites of tyrosine phosphorylation, is required for phosphorylation of SHC and p85, not for mitogenesis, thus allowing functional dissection of the signaling pathways activated by cytokines.

Citing Articles

Crosstalk between CAFs and tumour cells in head and neck cancer.

Li X, Gonzalez-Maroto C, Tavassoli M Cell Death Discov. 2024; 10(1):303.

PMID: 38926351 PMC: 11208506. DOI: 10.1038/s41420-024-02053-9.


Designing patient-oriented combination therapies for acute myeloid leukemia based on efficacy/toxicity integration and bipartite network modeling.

Mirzaie M, Gholizadeh E, Miettinen J, Ianevski F, Ruokoranta T, Saarela J Oncogenesis. 2024; 13(1):11.

PMID: 38429288 PMC: 10907624. DOI: 10.1038/s41389-024-00510-9.


2022 Cannon lecture: an ode to signal transduction: how the growth hormone pathway revealed insight into height, malignancy, and obesity.

Carter-Su C, Argetsinger L, Svezhova N Am J Physiol Endocrinol Metab. 2023; 325(5):E425-E437.

PMID: 37672248 PMC: 10874654. DOI: 10.1152/ajpendo.00265.2023.


Discovery of -(4-(Aminomethyl)phenyl)-5-methylpyrimidin-2-amine Derivatives as Potent and Selective JAK2 Inhibitors.

Tian Y, Qin S, Zhang F, Luo J, He X, Sun Y ACS Med Chem Lett. 2023; 14(8):1113-1121.

PMID: 37583815 PMC: 10424325. DOI: 10.1021/acsmedchemlett.3c00251.


Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer.

Xue C, Yao Q, Gu X, Shi Q, Yuan X, Chu Q Signal Transduct Target Ther. 2023; 8(1):204.

PMID: 37208335 PMC: 10196327. DOI: 10.1038/s41392-023-01468-7.